Licensing allows someone else to manufacture and sell a product while the creator collects fees, similar to collecting rent.
A simple idea, like a small component inside packaging, can generate income every time it is used.
#LicensingDeals #PassiveIncome #ProductRights
The conversation around AI and publisher compensation just got a bit more interesting.
Read more about News/Media Alliance’s new AI licensing deal 👇
www.magazinemanager.com/blog/publish...
#AI #AIlicensing #licensingdeals #AIpublishing #digitalpublishing #AIsoftware #MagazineManager
Deal takeaways - Strong platform validation for Shengyin’s RNAi chemistry and delivery technologies - Meaningful non-dilutive capital with retained upside via milestones and royalties - Genentech assumes late-stage development and commercialization risk, a classic risk-sharing structure - Signals continued Big Pharma appetite for RNAi assets, especially platform-driven programs From an investment perspective, this deal highlights how differentiated RNA platforms can command premium economics even at early clinical stages—and how large pharma is selectively re-entering RNAi with improved delivery solutions.
RNAi deal worth watching from an investment lens
SanegeneBio announced a global licensing agreement with Genentech (罗氏公司 Group) for an RNAi therapeutic, featuring $200M upfront, up to $1.5B in milestones, plus tiered royalties.
#BiotechInvesting #RNAi #LicensingDeals #PharmaBD #Roche #Genentech
#Jackiesrosegarden #ballroom #licensingdeals #kickbacks To wake up and find it was all a bad dream and there aren't 100M Americans who would have turned Anne Frank in...
#Jackiesrosegarden #ballroom #licensingdeals #kickbacks To wake up and find it was all a bad dream and there aren't 100M Americans who would have turned Anne Frank in...
